{"id":2809,"date":"2019-10-08T13:05:38","date_gmt":"2019-10-08T11:05:38","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=2809"},"modified":"2024-04-18T12:01:02","modified_gmt":"2024-04-18T10:01:02","slug":"image-diagnosis-and-nuclear-medicine","status":"publish","type":"page","link":"https:\/\/idibell.cat\/en\/research\/translational-medicine-area\/digestive-system-diagnostics-pharmacogenetics-care-support-and-clinical-prevention-program-2\/image-diagnosis-and-nuclear-medicine\/","title":{"rendered":"Image diagnosis and nuclear medicine"},"content":{"rendered":"\n

\n\t\tImage diagnosis and nuclear medicine\n\t<\/h1>\n

\n\t\tSummary\n\t<\/h3>\n\t

This group focusses its research on improving the diagnostic-imaging and nuclear-medicine techniques applied to various diseases, such as infectious and inflammatory diseases, and to various types of tumours.<\/p>\n

491<\/h2>\n

Publications<\/h2>\n\t\t\t\t\"big_mri\"\n\t\t\t\t\tStrategic lines<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\tDiagnosis of osteoarticular infection
\nDiagnosis of inflammatory bowel disease
\nRadioguided location of tumour lesions
\nSentinel lymph node in multifocal breast cancer and post-neoadjuvant chemotherapy
\nDevelopment of new methods for the quality control of Nuclear Medicine instruments
\nQuality Assurance Manual
\nRadiofrequency treatment of osteoid osteomas
\nVertebroplasty
\nRadiofrequency treatment of unresectable renal tumours
\nBotulinum toxin treatment of spastic shoulder pain in post-stroke patients and with pyramidal pain without response to conservative measures
\nNeurolytic blockade using rhizolysis
\nQuantification of bile acid absorption with 75Se-SEHCAT in chronic diarrhoea\n\t\t\t\t\t
Selected Publications<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t

Gin\u00e9,E;de la Cruz,F;Jim\u00e9nez Ubieto,A;L\u00f3pez Jimenez,J;Mart\u00edn Garc\u00eda Sancho,A;Terol,MJ;Gonz\u00e1lez Barca,E et al, Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial<\/strong>., J. Clin. Oncol., 2022;40(11):1196-1205, doi:10.1200\/JCO.21.02321<\/p>\n

Mils,K;Mir\u00f3,M;Farran,L;Videla,S;Alba,E;Estremiana,F;Bettonica,C et al, A pilot randomized controlled trial on the utility of gastric conditioning in the prevention of esophagogastric anastomotic leak after Ivor Lewis esophagectomy<\/strong>., Int. J. Surg., 2022;106106921-106921, doi:10.1016\/j.ijsu.2022.106921<\/p>\n

Requena,M;Ribo,M;Zamarro,J;Vega,P;Blasco,J;Gonz\u00e1lez,EM;Del Mar Freijo,M et al, Clinical Results of the Advanced Neurovascular Access Catheter System Combined With a Stent Retriever in Acute Ischemic Stroke (SOLONDA)<\/strong>., Stroke, 2022;53(7):2211-2219, doi:10.1161\/STROKEAHA.121.037577<\/p>\n

Font,M\u00c0;Garc\u00eda S\u00e1nchez,SM;Mengual,JJ;Mena,L;Avellaneda,C;Serena,J;Valls Carb\u00f3,A et al, Determinants and Trends of the Use of Intravenous Thrombolysis for Minor Stroke: A Population-Based Study, 2016 to 2020<\/strong>., Stroke, 2022;53(11):3289-3294, doi:10.1161\/STROKEAHA.122.038996<\/p>\n

Arribas,L;Sabat\u00e9 Llobera,A;Domingo,MC; Taberna,M; Sospedra,M; Martin,L; Gonz\u00e1lez Tamp\u00e1n,AR et al, Assessing dynamic change in muscle during treatment of patients with cancer: Precision testing standards<\/strong>., Clin. Nutr., 2022;41(5):1059-1065, doi:10.1016\/j.clnu.2022.03.016<\/p>\n\t\t\t\t\tSelected Projects<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t

18ACL106. A RANDOMIZED, OPEN-LABEL, MULTICENTER PHASE 3 STUDY TO COMPARE THE EFFICACY AND SAFETY OF BGB-A317 VERSUS SORAFENIB AS FIRST-LINE TREATMENT IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA<\/strong>. Budget: 30870. 2018- . PI: De Lama SALVADOR, M\u00aa Eugenia.<\/p>\n

19ACL037. A RANDOMIZED, CONTROLLED, OPEN-LABEL, GLOBAL PHASE 3 STUDY COMPARING THE EFFICACY OF THE ANTI-PD-1 ANTIBODY BGB-A317 VERSUS CHEMOTHERAPY AS SECOND LINE TREATMENT IN PATIENTS WITH ADVANCED UNRESECTABLE\/METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA<\/strong>. Budget: 1633,94. 2019- . PI: Calvo Malvar, Nahum.<\/p>\n

2022-113-1. TERAPIA CON RADIOP\u00c9PTIDOS EN PR\u00c1CTICA CL\u00cdNICA<\/strong>. Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (SEMNIM). 2022- . PI: Vercher Conejero, Jos\u00e9 Luis.<\/p>\n

14ACL069. ESTUDIO DE FASE II ABIERTO, ALEATORIZADO, DE TRES GRUPOS, DE DICLORURO DE RADIO-223 DE 50 kBq\/kg (55 kBq\/kg TRAS IMPLEMENTAR LA ACTUALIZACI\u00d3N DEL NIST) EN COMPARACI\u00d3N CON 80 kBq\/kg (88 kBq\/kg TRAS IMPLEMENTAR LA ACTUALIZACI\u00d3N DEL NIST) y 50 kBq\/kg (55 kBq\/kg TRAS IMPLEMENTAR LA ACTUALIZACI\u00d3N DEL NIST) EN UN PROGRAMA DE DOSIS AMPLIADO EN PACIENTES CON C\u00c1NCER DE PR\u00d3STATA RESISTENTE A LA CASTRACI\u00d3N CON MET\u00c1STASIS \u00d3SEA<\/strong>. 2014- . PI: Mora Salvado, Jaume.<\/p>\n

12ACL078. ESTUDIO EN FASE III ABIERTO, ALEATORIZADO, MULTIC\u00c9NTRICO, ESTRATIFICADO, DE COMPARADOR ACTIVO Y DE GRUPOS PARALELOS PARA COMPARAR EL TRATAMIENTO CON 177Lu-DOTA0-Tyr3-ACETATO DE OCTREOTIDA FRENTE A OCTREOTIDA DE ACCI\u00d3N PROLONGADA EN PACIENTES CON TUMORES CARCINOIDES DEL INTESTINO MEDIO IRRESECABLES, PROGRESIVOS, POSITIVOS PARA RECEPTORES DE SOMATOSTATINA<\/strong>. 2012-2023. PI: Mora Salvado, Jaume.<\/p>\n\t\t\t\t\"avatar-188\"\n

\n\t\tPrincipal investigators\n\t<\/h2>\n\t\t\t\t\"Nahum-Calvo-Malvar\"\n

\n\t\tCalvo Malvar, Nahum\n\t<\/h4>\n

\n\t\t\n\t\tncalvom@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"Montserrat-Cortes-Romera\"\n

\n\t\tCort\u00e9s Romera, Montserrat\n\t<\/h4>\n\t\t\t\t\"Aida-Sabate-Llobera\"\n

\n\t\tSabat\u00e9 Llobera, Aida\n\t<\/h4>\n

\n\t\t\n\t\tasabate@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n

\n\t\tTeam\n\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\tGroup leaders\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tPrincipal investigators\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tClinical researchers\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tPostdoctoral researchers \t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tScientific support\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tManagement support\t\t\t\t<\/a>\n\t\t\t\t\t\tGroup leaders\n\t\t\t\t\t\t\t\t\t\t\t